Last reviewed · How we verify
NCT06100510
PFA 100 Evaluation and Reference Interval HOACNY
Phase 4 trial testing Aspirin 325mg in Effect of Drug in 40 participants. Enrolling by invitation.
10 October 2024
Quick facts
| Lead sponsor | Hematology Oncology Associates of Central New York |
|---|---|
| Phase | Phase 4 |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 40 |
| Start date | 19 February 2024 |
| Primary completion | 10 October 2024 |
| Estimated completion | 10 October 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Aspirin 325mg — full drug profile →
Conditions studied
- Effect of Drug — all drugs for Effect of Drug →
Sponsor
Hematology Oncology Associates of Central New York
Who can join
18 and older, any sex, with Effect of Drug. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research is to evaluate instrument functionality and develop a reference range of normal data by healthy volunteers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06100510
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Aspirin 325mg
Trials testing the same drug.
- NCT04697719 — Body Weight, Aspirin Dose and Pro-resolving Mediators · Phase 4 · completed
- NCT04066725 — Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma · Phase 2 · completed
- NCT03152409 — Salicylic Augmentation in Depression · Phase 2 · terminated
- NCT03244020 — LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology · Phase 4 · enrolling by invitation
- NCT04062032 — Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma · Phase 2 · completed
Other recruiting trials for Effect of Drug
Currently open trials in the same condition.
- NCT07037511 — Effects of Salbutamol in Athletes and Implications for Screening and Sports · NA · recruiting
- NCT06575530 — Sedation Efficacy and Safety of Remazolam Besylate in Ventilated Surgical Critically Ill Patients · Phase 4 · recruiting
- NCT06562816 — Comparing Trypsin-Chymotrypsin and Naproxen Sodium for Post-endodontic Treatment Pain · Phase 4 · recruiting
- NCT06479655 — Compare the Efficacy and Outcome Between Fentanyl and Morphine as Analgo-sedation in Mechanically Ventilated Patients · Phase 4 · recruiting
- NCT06000462 — The Effect of Dapagliflozin on Weight Loss in Obese Adults Without Diabetes · Phase 4 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06100510 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hematology Oncology Associates of Central New York
- Last refreshed: 3 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06100510.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing